Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.
about
Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversityStudy-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.Triage of HPV positive women in cervical cancer screening.The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningClinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Improving Laboratory Efficiency by Automation of Preanalytic Processing of ThinPrep Specimens for Real-Time PCR High-Risk HPV Testing.Human papillomavirus test with cytology triage in organized screening for cervical cancer.Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.
P2860
Q35843279-18AD94DD-0BDC-4E2A-B021-14A5EAD530F2Q36190228-B7F14207-85C0-4336-ABDF-8A84794D6977Q36679896-8F0F320E-7DFE-4CEB-945A-EC2C2D4B86EDQ37218627-D318F44A-E753-4B89-BB7C-85B3F3AFE02FQ37470374-77BB9D51-82B9-4184-8F54-3686B97A669EQ37643509-30295D25-B378-4217-9679-0EE130BBE929Q38180277-6AAAB72D-FCD5-44D6-A9BE-0BB3EEBB5AF8Q38387930-1B76DB1B-3A28-4DF9-82B8-6CA4C23BDE27Q38809544-762E067D-6AD3-41F2-8889-D2A21BA8655AQ47159754-B5FFE666-2A48-41FC-9030-7F93E958E44E
P2860
Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical validation of the Abb ...... ements for cervical screening.
@en
type
label
Clinical validation of the Abb ...... ements for cervical screening.
@en
prefLabel
Clinical validation of the Abb ...... ements for cervical screening.
@en
P2093
P2860
P356
P1476
Clinical validation of the Abb ...... ements for cervical screening.
@en
P2093
A T Hesselink
C J L M Meijer
D A M Heideman
F J van Kemenade
M Bogaarts
M L van der Salm
P J F Snijders
P2860
P304
P356
10.1128/JCM.00633-13
P407
P577
2013-05-01T00:00:00Z